Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Isosorbide Mononitrate Tablet Market Forecast: Value Set To Climb From $1.26 Billion To $1.55 Billion
The isosorbide mononitrate tablet market has demonstrated substantial growth in recent years. This market is anticipated to expand from $1.2 billion in 2025 to $1.26 billion in 2026, with a compound annual growth rate (CAGR) of 5.3%. Key drivers for this historical expansion include the growing incidence of coronary artery disease, the prolonged use of nitrates for angina treatment, the expanding elderly population, the presence of affordable generic drugs, and the enhancement of hospital and retail pharmacy networks.
The market for isosorbide mononitrate tablets is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $1.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this expansion during the projection period include an increase in chronic cardiovascular ailments, a growing need for extended-release formulations, the wider acceptance of online pharmacy services, enhanced detection of angina and heart failure, and greater availability of cardiovascular medications in developing regions. Key developments expected during the forecast timeframe encompass long-duration cardiovascular maintenance treatments, an increasing inclination towards extended-release dosage forms, the escalating consumption of generic nitrate drugs, better patient compliance achieved via once-daily administration, and broadened access to both online and physical retail pharmacies.
Get A Free Sample Report With In-Depth Market Insights:
Isosorbide Mononitrate Tablet Market Growth Momentum: What Factors Are Shaping Demand?
An increasing incidence of cardiovascular diseases is anticipated to drive the expansion of the isosorbide mononitrate tablet market in the future. These conditions, known as CVDs, encompass a range of ailments impacting the heart and blood vessels, such as coronary artery disease, heart failure, and hypertension. The growing occurrence of cardiovascular diseases mainly stems from unwholesome dietary habits, frequently characterized by significant amounts of saturated fats, trans fats, sodium, and added sugars, resulting in issues like obesity, hypertension, and elevated cholesterol. Isosorbide mononitrate tablets aid in the management of cardiovascular diseases through their action of relaxing and expanding blood vessels, which subsequently enhances blood flow and diminishes the heart’s exertion. This mechanism effectively relieves chest pain (angina), decreases blood pressure, and boosts oxygen supply to the heart muscle. As an illustration, the Global Burden of Disease study, as reported by the American College of Cardiology, a US-based nonprofit medical association and professional society for cardiologists, indicated 19.2 million cardiovascular disease deaths globally in 2023, with this information highlighted in September 2025. Consequently, the increasing incidence of cardiovascular diseases is serving as a catalyst for the expansion of the isosorbide mononitrate tablet market.
Isosorbide Mononitrate Tablet Market Segment Breakdown: Which Categories Lead On Revenue?
The isosorbide mononitrate tablet market covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets
2) By Indication Type: Angina Pectoris, Coronary Artery Disease (CAD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets
2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation
Isosorbide Mononitrate Tablet Market Trends Redefining Industry Growth
Leading companies within the isosorbide mononitrate tablet market are concentrating on developing innovative products like extended-release (ER) formulations to enhance patient compliance, provide sustained therapeutic effects, and optimize treatment outcomes for conditions such as angina pectoris. An extended-release formulation is an advanced drug delivery system designed to allow for the gradual release of medication over an extended period, thereby reducing dosing frequency and maintaining consistent blood levels. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, received approval from the United States Food and Drug Administration (USFDA) to manufacture and market isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are prescribed to prevent chest pain (angina) in patients with coronary artery disease and are considered equivalent to the reference listed drug (RLD), imdur extended-release tablets.
Isosorbide Mononitrate Tablet Market Leading Players And Competitive Positioning
Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Qilu Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd.
View The Full Isosorbide Mononitrate Tablet Market Report:
Isosorbide Mononitrate Tablet Market Geographic Spread And Regional Opportunities
North America was the largest region in the isosorbide mononitrate tablet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
